{Reference Type}: Journal Article
{Title}: CDC Prioritizes HIV Prevention and Treatment to Reduce HIV Disparities Among Cis-Gender Black Women.
{Author}: Raiford JL;DiNenno E;Beer L;Bowman S;Johnson Lyons S;Anderson SKE;Powell N;Nickson R;Hall G;Neblett Fanfair R; ;
{Journal}: J Womens Health (Larchmt)
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 5
{Factor}: 3.017
{DOI}: 10.1089/jwh.2024.0472
{Abstract}: To succeed in ending the HIV epidemic in the United States, the Centers for Disease Control and Prevention (CDC) focuses on delivering combinations of scientifically proven, cost-effective, and scalable interventions to priority populations. Systemic factors continue to contribute to persistent health disparities and disproportionately higher rates of HIV diagnosis in some communities. The National HIV/AIDS Strategy has designated cis-gender Black women (CgBW) as a priority population to address the racial and ethnic inequities in HIV. This report presents the portfolio of projects, programs, and initiatives funded by the CDC's Division of HIV Prevention (DHP) to address disparities in HIV and improve health and QOL among CgBW. These funded activities include the development, planning, and implementation of HIV prevention programs, mass media campaigns, and behavioral interventions focused on CgBW. This report also summarizes DHP's community engagement, capacity building, and partnership efforts, and highlights research and surveillance activities focusing on CgBW. Finally, this report outlines future directions for CDC's efforts to improve access to HIV testing, treatment, and prevention for CgBW in the United States.